News & Views

News and Opinions


Thirty civil society groups met to find strategies on antibiotic resistance - resulted in input to IACG meeting

Mid May, members of the ARC Coalition and other civil society partners convened in Geneva for a conference. ReAct was one of the organizers. A key decision point that emerged was the need for concerted civil society input into the IACG meeting end May.


Mass administration of antibiotics does not solve the root cause of child mortality in Africa

According to UNICEF, the estimated mortality rate in children under 5 years in sub-Saharan Africa in 2016 was 78.4 deaths per 1000 live births. We all share a responsibility to reduce these mortality rates, but how?


71st WHA: tuberculosis multisectoral accountability framework - parallels with the antibiotic resistance debate

In September a high-level meeting on tuberculosis will take place during the UN General Assembly. In preparation fhe World Health Assembly will adopt a resolution which includes the proposal for a multisectoral accountability framework. There are parallels between the accountability framework and the antibiotic resistance debate.


ReAct Europe keynote speaker at side event at 71st World Health Assembly

Wednesday, Thomas Tängdén, Medical Director, ReAct Europe, was one of the keynote speakers at one of the side events at 71st World Health Assembly in Geneva, Switzerland. Theme: “Establishing antibiotic efficacy as a global public good”.


71st World Health Assembly - antibiotic resistance absent from the agenda

This week is the week of the 71st World Health Assembly in Geneva, Switzerland. While antibiotic resistance is not specifically on the agenda this year, the general work programme for the WHO covers antimicrobial resistance and other relevant topics related to access to medicines will be discussed.


Rise in global antibiotic consumption between 2000 and 2015 – what can we learn from the latest study?

According to a recent publication in the Proceedings of the National Academy of Science, global antibiotic consumption in humans has increased dramatically from 2000 to 2015. The study rings a bell on the complex challenges posed by underuse, misuse and overuse of antibiotics.


Towards stronger global governance for AMR

As global attention and political will to address the rising tide of antibiotic resistance has increased over the last years, and a wider range of actors starting to become involved in the field, the urgency of developing global governance of antimicrobial resistance (AMR) is growing.


ReAct Latin America: A workshop to reach commitments

Mid May, La Paz, Bolivia, will host the International Workshop Seminar “Understanding Antimicrobial Resistance, Caring the Health of Mother Earth, Healing Us”.

An event that brings together professionals from Bolivia, El Salvador, Argentina, Colombia, Ecuador, India, Australia and Sweden, to address antibiotic resistance from a One Health perspective.

ReAct Interview

Caring about antibiotic resistance is similar with reducing the plastic waste or saving water

“Caring about antibiotic resistance is similar to reducing plastic waste or saving water”, says Dr. Windhi Kresnawati. She is a pediatrician and has worked in a remote area in Indonesia for the past 4 years. During this time she managed to engage various stakeholders to support and participate in a series of activities to raise their awareness on antibiotic resistance.

World Health Day

The rise and fall of antibiotics?

As we recently commemorated the World Health Day, it is interesting to remind us all of the rise and approaching fall of one of the most powerful discoveries in medical history – antibiotics. What makes them so special, and why is bacterial resistance such a major threat to human health?

ReAct Africa shares experiences on CSO engagement at 71st World Health Assembly

This 71st session of the World Health Assembly offers a unique space for health specialists, in a multitude of areas affecting global health and its future, to interact, share and learn. At this year’s assembly, Mirfin Mpundu, Head of React Africa, contributed to a side brainstorming event for civil society with the title: “AMR Control: Are We Off Track?”


Antibiotics in wastewater from pharmaceutical companies: Where are we at?

Over the last years pharmaceutical companies made commitments for change and curbing antibiotic waste has been voiced as one of their top priorities. This year we grab the opportunity at World Water Day to look where we are at now: Have pharmaceutical companies taken action on their own commitments? And how are governments tackling this issue?


Book release in Latin America: an arena for reflection, awareness and care about antibiotics

To analyze the consequences of antibiotic resistance and possibilities of containing antibiotic resistance ReAct Latin America arranged an event at the University of Cuenca, Ecuador, releasing the book Madre Tierra: Una Sola Salud, in commemoration of World Health Day.


Unavailability of old antibiotics is threatening effective treatment of common bacterial infections

In a commentary in The Lancet Infectious Diseases, leading experts from ReAct and other key stakeholder groups discuss the increasing problem with lack of availability of essential antibiotics.



Why are fixed dose combinations of antibiotics generally not a good idea?

Fixed dose combinations are pharmaceutical products such as tablets, ointments or suspensions where two or more antibiotics are combined in one product. In the treatment of Tuberculosis and HIV, they are vital for treatment success as they improve compliance and reduce development of resistance. In theory, it sounds like a good idea to copy this success to other bacteria and antibiotic resistance, but in practice it is generally not so.


New expert advisory group for the ReAct Toolbox

ReAct is very glad to announce the establishment of an expert advisory group for our web-based Toolbox for action on antibiotic resistance. The advisory group is composed of renowned experts from the antibiotic resistance field.


ReAct reflections on the Prince Mahidol Award Conference and the IACG Civil Society Engagement Panel

Given the strong emphasis on antimicrobial resistance, several people from ReAct joined the conference and discussions on sustainable solutions to contain antibiotic resistance. Antimicrobial resistance was at the top of the agenda, and for the first time at a high-level conference prominently discussed as an emerging infectious disease.


From the Regional Stakeholders’ Summit in Cape Town: 4 needs to address so diagnostics can help contain antimicrobial resistance

How can diagnostics contribute to contain antimicrobial resistance? That was the main question during the Regional Stakeholders’ Summit in Cape Town end January. ReAct Africa has summarized a list of the most mentioned needs that need to be attended to.


4 take aways from the newly published GLASS report

End January, the first report from the WHO Global Antimicrobial Resistance Surveillance System (GLASS) was released. ReAct summarizes 4 take aways from the report.


ReAct responds to final report from DRIVE-AB

The DRIVE-AB consortium has worked to develop recommendations on how to change the innovation system to revitalize the antibiotic pipeline, while ensuring sustainable use and access. Now it published their final report. Anna Zorzet, Head of ReAct Europe, says:

“Ensuring affordable and sustainable access to new antibiotics without risking excess in all countries should be at the crux of the R&D financing discussions – not placed as an afterthought.”


WHO proposes new sepsis target to guide work and actions on antibiotic resistance

January 22-27, the WHO will hold its 142nd meeting of the Executive Board in Geneva. The discussions are likely to be dominated by the draft General Work Program for 2019-2023. A new target on reducing sepsis cases by 10% is introduced as a benchmark for the field of antibiotic resistance.


Antibiotic resistance on agenda for The Prince Mahidol Award Conference: A policy stage led by low and middle income countries

Under the theme “Making the World Safe from the Threats of Emerging Infectious Diseases”, this year’s Prince Mahidol Award Conference (PMAC) 2018 will give the challenge of antibiotic resistance prominent attention. ReAct will have several people attending the conference to present and engage in the discussions.


Joint letter to IACG on AMR: A call to increase transparency and civil society involvement

ReAct, together with other members of the Antibiotic Resistance Coalition (ARC) has written a joint letter to the UN Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance to call on the group to increase the transparency of, and civil society involvement in, its policy deliberation and meeting process.


Costing National Action Plans on AMR: Practical suggestions for simplifying the process

Costing a country’s National Action Plan on AMR appears to be a daunting and challenging task. As Dr. Kim Faure has great experience on costing National Action Plans on AMR ReAct interviewed her to help countries with som practical steps in the process.


ReAct wishes for 2018 – node by node

We would like to thank you for 2017 with wishes for an exciting 2018!

Here you find ReAct wishes for 2018, node by node. Together we can make a difference.